Since there are few, if any, IM models that have been
rigorously evaluated in terms of CBA, it is possible to draw
upon the cost-effectiveness research focused on a limited
number of CAM modalities, as well as from the work-site/
corporate clinical and cost outcomes research to suggest analyses
necessary to develop the evidence-based foundation
from which an effective, efficient, and personalized healthcare
system will evolve.